XML 35 R17.htm IDEA: XBRL DOCUMENT v3.24.3
Goodwill
 12 Months Ended
Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill GOODWILL
The changes in the carrying amount of goodwill by segment are presented in the following table.
Post Consumer BrandsWeetabixFoodserviceRefrigerated RetailTotal
Balance, September 30, 2022
Goodwill (gross)$2,066.8 $781.6 $1,355.3 $803.7 $5,007.4 
Accumulated impairment losses(609.1)— — (48.7)(657.8)
Goodwill (net)$1,457.7 $781.6 $1,355.3 $755.0 $4,349.6 
Goodwill from acquisitions
194.2 — — — 194.2 
Impairment loss— — — (42.2)(42.2)
Currency translation adjustment0.1 72.7 — — 72.8 
Balance, September 30, 2023
Goodwill (gross)$2,261.1 $854.3 $1,355.3 $803.7 $5,274.4 
Accumulated impairment losses(609.1)— — (90.9)(700.0)
Goodwill (net)$1,652.0 $854.3 $1,355.3 $712.8 $4,574.4 
Goodwill from acquisition43.2 — — — 43.2 
Currency translation adjustment— 83.1 — — 83.1 
Balance, September 30, 2024
Goodwill (gross)$2,304.3 $937.4 $1,355.3 $803.7 $5,400.7 
Accumulated impairment losses(609.1)— — (90.9)(700.0)
Goodwill (net)$1,695.2 $937.4 $1,355.3 $712.8 $4,700.7 
During the year ended September 30, 2023, the Company recorded a goodwill impairment charge of $42.2 related to its Cheese and Dairy reporting unit within the Refrigerated Retail segment, which was recorded in “Impairment of goodwill” in the Consolidated Statements of Operations. The goodwill impairment charge was driven primarily by narrowing of the pricing gap between branded and private label competitors, resulting in distribution losses and declining profitability. The Company did not record a goodwill impairment charge during the years ended September 30, 2024 or 2022, as all reporting units subjected to the quantitative test passed during each respective year.
At September 30, 2024, the Cheese and Dairy and Weetabix reporting units’ fair values exceeded their carrying values by approximately 5.3% and 5.2%, respectively. The Cheese and Dairy reporting unit was impacted by the narrowing of the pricing
gap between branded and private label competitors, resulting in distribution losses. The Weetabix reporting unit was impacted by cost inflation as well as U.K. economic pressures negatively impacting consumer spending trends, both of which impacted near-term profitability. The Company expects these impacts to be transitory in nature; however, inherent risk to the reporting units’ cash flows remains. Variances between the actual performance of the reporting units and the assumptions that were used in developing the estimates of fair value could result in impairment charges in future periods. The estimated fair values of all other reporting units exceeded their carrying values by at least 18% at September 30, 2024.
At September 30, 2023, the Weetabix reporting unit fair value exceeded its carrying value by approximately 6.4% and the estimated fair values of all other reporting units exceeded their carrying values by at least 13%.